Literature DB >> 21785908

Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.

Troels Isaksen1, Christian Stoltz Nielsen, Signe Engkjær Christensen, Peter H Nissen, Lene Heickendorff, Leif Mosekilde.   

Abstract

Studies have shown that cancellous bone is relatively preserved in primary hyperparathyroidism (PHPT), whereas bone loss is seen in cortical bone. Familial hypocalciuric hypercalcemia (FHH) patients seem to preserve bone mineral in spite of hypercalcemia and often elevated plasma parathyroid hormone (PTH). The objective of this study was to compare total and regional forearm bone mineral density (BMD) in patients with PHPT and FHH and to examine if differences can be used to separate the two disorders. We included 63 FHH, and 121 PHPT patients in a cross-sectional study. We performed dual-energy X-ray absorptiometry scans of the forearm, hip and lumbar spine and measured a number of biochemical variables. PTH patients had significantly lower Z-scores in all parts of the forearm compared to FHH. This was also the case after adjustment for body mass index. When stratifying for age, gender and PTH, T-scores were still significantly lower in PHPT patients than in FHH patients at the total, the mid and the ultradistal forearm, but not at the proximal 1/3 forearm. In a multiple regression analysis BMD Z-score was lower in PHPT compared to FHH at the total forearm, the mid forearm and the ultradistal forearm but not the proximal forearm when adjusting for biochemical variables including PTH, 1,25(OH)(2)D and Ca(2+). These observations support that inactivating mutations in the CASR gene in bone cells in FHH may protect against forearm bone loss. Differences between the two groups in total or regional forearm BMD were inferior to the calcium/creatinine clearance ratio as a diagnostic tool to separate FHH from PHPT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785908     DOI: 10.1007/s00223-011-9517-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  9 in total

1.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

Review 2.  The calcium-sensing receptor in bone--mechanistic and therapeutic insights.

Authors:  David Goltzman; Geoffrey N Hendy
Journal:  Nat Rev Endocrinol       Date:  2015-03-10       Impact factor: 43.330

3.  Hypercalcemia caused by comorbid parathyroid adenoma and pulmonary tuberculosis.

Authors:  Sahoko Kamejima; Izumi Yamamoto; Arisa Kobayashi; Akio Nakashima; Taketo Uchiyama; Ichiro Ohkido; Takashi Yokoo
Journal:  CEN Case Rep       Date:  2020-07-06

4.  Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.

Authors:  K Zajíčková; M Dvořáková; J Moravcová; J Včelák; D Goltzman
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

Review 5.  Osteoporosis in men: recent progress.

Authors:  Robert A Adler
Journal:  Endocrine       Date:  2013-01-25       Impact factor: 3.633

6.  A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.

Authors:  Johan Halse; Susan Greenspan; Felicia Cosman; Graham Ellis; Arthur Santora; Albert Leung; Norman Heyden; Suvajit Samanta; Steven Doleckyj; Elizabeth Rosenberg; Andrew E Denker
Journal:  J Clin Endocrinol Metab       Date:  2014-08-28       Impact factor: 5.958

Review 7.  Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Bruno Carnaille; F Fausto Palazzo; Menno Vriens
Journal:  Langenbecks Arch Surg       Date:  2015-10-08       Impact factor: 3.445

Review 8.  Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.

Authors:  Maryam Zahedi; Reyhane Hizomi Arani; Maryam Rafati; Atieh Amouzegar; Farzad Hadaegh
Journal:  BMC Endocr Disord       Date:  2021-11-04       Impact factor: 2.763

9.  Clinical, Biochemical, and Genetic Profile of an Indian Kindred with Type 1 Familial Hypocalciuric Hypercalcemia.

Authors:  Sarah Alam; Alpesh Goyal; Nikhil Tandon
Journal:  Indian J Endocrinol Metab       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.